Information:
Error:
ID
20836
Description
rEEG Guided Pharmacotherapy of Subjects With Depression Treatment Failure; ODM derived from: https://clinicaltrials.gov/show/NCT00437827
Link
https://clinicaltrials.gov/show/NCT00437827
Keywords
Versions (1)
- 3/21/17 3/21/17 -
Uploaded on
March 21, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Depressive Disorder NCT00437827
Eligibility Depressive Disorder NCT00437827
- StudyEvent: Eligibility
Similar models
Eligibility Depressive Disorder NCT00437827
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Age
Item
1. 18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
Major depressive disorder
Item
2. diagnosis of major depressive disorder validated by scid. subjects may meet criteria for both melancholic and atypical depression per this protocol.
boolean
C1269683 (UMLS CUI [1])
Antidepressive therapy
Item
3. have failed three or more antidepressant regimens during the current depressive episode with minimum daily dose(s) as defined in the medication history for depression case report form and for a minimum duration of treatment of at least 4 weeks. for purposes of the study, augmentation will be considered a separate regimen.
boolean
C0003289 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
Discontinued pharmacotherapy
Item
4. able to stop all medications for 5 half-lives of the medication(s), with the exception of hormones, thyroid, hydrochlorthiazide and ambien. see appendix ii for a list of the half-lives of medications.
boolean
C1444662 (UMLS CUI [1,1])
C0013216 (UMLS CUI [1,2])
C0013216 (UMLS CUI [1,2])
Neurological disease or mental disorder
Item
1. history of: closed head injury with unconsciousness, craniotomy, cerebral metastases, cerebrovascular accident; no current diagnosis of seizure disorder, bipolar disorder, schizophrenia, dementia, mental retardation, substance abuse, or major depression with psychotic features; or use of depot neuroleptics in last 12 months.
boolean
C0027765 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
C0004936 (UMLS CUI [2])
Study participation status
Item
2. participation in any other therapeutic drug study evaluating a treatment for depression within 60 days preceding inclusion, unless drug(s) half-life is known.
boolean
C2348568 (UMLS CUI [1])
Gynaecological status
Item
3. known pregnancy and/or lactation, or intent to become pregnant during this study.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
EEG analysis
Item
4. doesn't qualify via reeg analysis due to:
boolean
C0374458 (UMLS CUI [1])
Physiological abnormality
Item
potential physiologic abnormality
boolean
C1704258 (UMLS CUI [1,1])
C0205463 (UMLS CUI [1,2])
C0205463 (UMLS CUI [1,2])
Low abnormality
Item
low abnormality in comparison to current reeg database
boolean
C1704258 (UMLS CUI [1,1])
C0205251 (UMLS CUI [1,2])
C0205251 (UMLS CUI [1,2])
Prediction
Item
no strong prediction by reeg analysis for any particular medication class
boolean
C0681842 (UMLS CUI [1])